Detection of hepatic micrometastases in the context of adjuvant chemotherapy and surgery for hepatic metastases;Nachweis hepatischer Mikrometastasen: Einsatz im Kontext der adjuvanten Chemotherapie und der Lebermetastasenchirurgie?

Deutsche Medizinische Wochenschrift

Volumn 135, Issue 21, 2010, Pages 1078-1082

  Schimanski, C C ^a   Mohler M ^a   Zimmermann, T ^a   Gockel, I ^a   Lang, H ^a   Arbogast, R ^b   Jager D ^c   Galle, P R ^a   Berger, M R ^d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Klinikum Pforzheim GmbH   (Germany)

^c Nationales Centrum fur Tumorerkrankungen   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Colorectal cancer; Disseminated tumor cells; Micrometastases; Surgery for liver metastases

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; CYTOKERATIN 20; FLUOROURACIL; GUANYLATE CYCLASE; OXALIPLATIN; PANITUMUMAB; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY; TACSTD1 PROTEIN, HUMAN; TUMOR ANTIGEN;

CANCER ADJUVANT THERAPY; COLORECTAL CARCINOMA; HUMAN; LIVER METASTASIS; LIVER RESECTION; MICROMETASTASIS; MOLECULAR GENETICS; PERITONEUM LAVAGE; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; ADJUVANT CHEMOTHERAPY; CANCER STAGING; COLORECTAL TUMOR; IMMUNOLOGY; LIVER TUMOR; METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRACTICE GUIDELINE; SURVIVAL RATE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL ADHESION MOLECULES; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SURVIVAL RATE;

EID: 77952980164     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1253703     Document Type: Review

References (38)

1. Becker M, Nitsche A, Neumann C et al. Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br J Cancer 2002 87 1328-1335
2. Bilchik A J., Hoon D S., Saha S et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 2007 246 568-575; 575577
3. Bosch B, Guller U, Schnider A et al. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg 2003 90 882-888
4. Conzelmann M, Dieterle C P., Linnemann U, Berger M R. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients. Int J Cancer 2003 107 617-628
5. Conzelmann M, Linnemann U, Berger M R. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? Int J Colorectal Dis 2005 20 137-146
6. Conzelmann M, Linnemann U, Berger M R. Detection of disseminated tumour cells in the liver of cancer patients. Eur J Surg Oncol 2005 31 977-985 (Pubitemid 41671111)
7. Cui J H., Krueger U, Henne-Bruns D, Kremer B, Kalthoff H. Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases. World J Gastroenterol 2001 7 381-386
8. De Jong M C., Pulitano C, Ribero D et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009 250 440-448
9. Fong Y, Cohen A M., Fortner J G. et al. Liver resection for colorectal metastases. J Clin Oncol 1997 15 938-946
10. Fong Y, Fortner J, Sun R L., Brennan M F., Blumgart L H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999 230 309-318
11. Ikawa K, Terashima Y, Sasaki K, Tashiro S. Genetic detection of liver micrometastases that are undetectable histologically. J Surg Res 2002 106 124-130
12. Kato T, Yasui K, Hirai T et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 2003 46 S22-31
13. Kienle P, Koch M, Autschbach F et al. Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer. Ann Surg 2003 238 324-330
14. Koch M, Kienle P, Logan E et al. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis. Ann Surg Oncol 2007 14 810-817
15. Konopke R, Distler M, Ludwig S, Kersting S. Location of liver metastases reflects the site of the primary colorectal carcinoma. Scand J Gastroenterol 2008 43 192-195
16. Koyanagi K, Bilchik A J., Saha S et al. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res 2008 14 7391-7396
17. Leonard G D., Brenner B, Kemeny N E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005 23 2038-2048
18. Linnemann U, Schimanski C C., Gebhardt C, Berger M R. Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. Int J Colorectal Dis 2004 19 380-386
19. Mitry E, Fields A L., Bleiberg H et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008 26 4906-4911
20. Naundorf S, Preithner S, Mayer P et al. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment. Int J Cancer 2002 100 101-110
21. Nordgard O, Aloysius T A., Todnem K, Heikkila R, Ogreid D. Detection of lymph node micrometastases in colorectal cancer. Scand J Gastroenterol 2003 38 125-132
22. Nordlinger B, Sorbye H, Glimelius B et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008 371 1007-1016
23. Portier G, Elias D, Bouche O et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006 24 4976-4982
24. Poston G J., Adam R, Alberts S et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 2005 23 7125-7134
25. Prang N, Preithner S, Brischwein K et al. Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines. Br J Cancer 2005 92 342-349
26. Schimanski C C., Linnemann U, Arbogast R, Berger M R. Extended staging results from the detection of isolated tumor cells in the liver of colorectal cancer patients. Oncol Rep 2001 8 185-188
27. Schimanski C C., Linnemann U, Berger M R. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Cancer Res 1999 59 5169-5175
28. Schimanski C C., Linnemann U, Galle P R., Arbogast R, Berger M R. Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications. Int J Oncol 2003 23 791-796
29. Schmiegel W, Reinacher-Schick A, Arnold D et al. [Update S3-guideline colorectal cancer 2008]. Z Gastroenterol 2008 46 799-840
30. Schuster R, Max N, Mann B et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 2004 108 219-227
31. Stein T N., Berger M R. Quantification of liver metastases from LS174T human colorectal cancer cells in nude rats by PCR. Anticancer Res 1999 19 3939-3945
32. Tobkes A I., Nord H J. Liver biopsy: review of methodology and complications. Dig Dis 1995 13 267-274
33. Topal B, Aerts J L., Roskams T et al. Cancer cell dissemination during curative surgery for colorectal liver metastases. Eur J Surg Oncol 2005 31 506-511
34. Vogel I, Shen Y, Soeth E et al. A human carcinoma model in athymic rats reflecting solid and disseminated colorectal metastases. Langenbecks Arch Surg 1998 383 466-473
35. Weitz J, Kienle P, Magener A et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999 5 1830-1836
36. Wigmore S J., Madhavan K, Redhead D N., Currie E J., Garden O J. Distribution of colorectal liver metastases in patients referred for hepatic resection. Cancer 2000 89 285-287
37. Yamaguchi K, Chijiiwa K, Torato N, Kinoshita M, Tanaka M. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer. Am J Gastroenterol 2000 95 1939-1945
38. Yokoyama N, Shirai Y, Ajioka Y et al. Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases. Cancer 2002 94 1642-1647